Announcement on Serious Abnormal Fluctuations in Stock Trading and Risk Warning
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Serious Abnormal Fluctuations in Stock Trading and Risk Warning
Filed with SSE · · 5 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-serious-abnormal-fluctuations-in-stock-trading-and-risk-warning-2
Release
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Earlier from Tianjin Tianyao Pharmaceuticals
- Announcement on Receiving Results of GMP Compliance Inspection Concerning Drugs by the Subsidiary
- Indicative Announcement on Stock Trading Risk
- Announcement on Resolutions of the 25th Meeting of the 9th Board of Directors
- Announcement on Changing Signatory Certified Public Accountant
- Corrective Action Report on Measures Taken by the Tianjin Office of China Securities Regulatory Commission to Order the Company to Make Corrections and Issue Warning Letters to Relevant Personnel
Later from Tianjin Tianyao Pharmaceuticals
- Announcement on the 2025 Evaluation Report on ""Corporate Value and Return Enhancement"" and 2026 Action Plan
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Resolutions of the 2025 Annual General Meeting
- Indicative Announcement on Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.'s Proposed Public Solicitation of a Transferee for 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd.
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals